Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

IL-1RA Protein, Human, Recombinant V2

Catalog No. TMPY-00853U

IL-1RA Protein, Human, Recombinant V2 is expressed in E. coli. The accession number is P18510.

IL-1RA Protein, Human, Recombinant V2

IL-1RA Protein, Human, Recombinant V2

Catalog No. TMPY-00853U
IL-1RA Protein, Human, Recombinant V2 is expressed in E. coli. The accession number is P18510.
Pack SizePriceAvailabilityQuantity
Bulk & Custom
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
View More

Product Information

Biological Activity
Immobilized Human AXL-His at 10 μg/ml (100 μl/well) can bind Human GAS6-His*.*: Biotinylated by NHS-biotin prior to testing The ED50 of Recombinant Human GAS6-His* is 0.04466 μg/ml. (Regularly tested)
Description
IL-1RA Protein, Human, Recombinant V2 is expressed in E. coli. The accession number is P18510.
Species
Human
Expression System
E. coli
TagTag Free
Accession NumberP18510
Synonyms
MVCD4,IRAP,interleukin 1 receptor antagonist,IL-1RN,IL-1ra3,IL-1ra,IL1RA,IL1F3,ICIL-1RA,DIRA
Construction
Arg26-Glu177
Protein Purity
> 95% as determined by SDS-PAGE
Molecular Weight17.26 kDa (Predicted); 18 kDa (Reducing conditions)
Endotoxin< 1.0 EU/μg of the protein as determined by the LAL method.
FormulationLyophilized from a 0.2 μm filtered solution of 20 mM PB, 8% Trehalose, 4% Mannitol, 50 mM NaCl, 0.05% Tween80, pH7.5.
Stability & Storage
Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.
ShippingIn general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice.
Research Background
Interleukin-1 Receptor Antagonist (IL-1RN) is a member of the IL-1 family. Endogenous IL-1RN is produced in numerous animal disease models as well as in human autoimmune and chronic inflammatory diseases. It binds to IL-1 receptors in competition with IL-1, but does not elicit intracellular response from this binding. Its role in counteracting the proinflammatory effects of IL-1 is being studied by numerous research groups. IL-4 and IL-13 have been shown to amplify the stimulatory effect of IL1-beta on the production of soluble and intracellular forms of IL-1RN. The regulated expression of IL-1RN in various cell types has been shown to be influenced by cytokines. In synovial fibroblasts, IL-1, TNF-alpha, or PDGF markedly enhances the synthesis of IL-1RN.

Dose Conversion

You can also refer to dose conversion for different animals. More

Sci Citations

Calculator

  • Reconstitution Calculator
  • Recombinant Protein Dilution Calculator
  • Specific Activity Calculator

Tech Support

Please read the User Guide of Recombinant Proteins for more specific information.

Keywords